Assessment of p16/CDKN2A copy number can be used as an ancillary test to help reach a conclusion about the grade of a chondrosarcoma thereby providing additional information on which to decide clinical management of this disease. The gene discussed is CDKN2A; the disease is chondrosarcoma.